glp-1 and kidneys receptor agonists next-generation metabolic hormone therapies in chronic kidney disease Glucagon-Like Peptide-1 Receptor Agonist Use
Description
Dietary linoleic acid and the ratio of unsaturated to saturated fatty acids are inversely associated with significant liver fibrosis risk: a nationwide survey
As research continues, the role of GLP-1 therapies in improving blood pressure and long-term health outcomes will likely become even more significant
99 , 24572466 (2014) S
doi: 10.1093/ajcn/60.6.895 35 CrossGBMarleyJMilesHWillsonK
Several clinical scenarios warrant prompt consultation with your healthcare provider
